SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,000 | -98.9% | 46 | -99.1% | 0.00% | -96.0% |
Q2 2020 | $847,000 | -6.0% | 4,983 | -36.2% | 0.08% | -21.9% |
Q1 2020 | $901,000 | -45.0% | 7,809 | -45.6% | 0.10% | -23.8% |
Q4 2019 | $1,639,000 | +703.4% | 14,345 | +148.4% | 0.13% | +180.0% |
Q1 2015 | $204,000 | – | 5,775 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |